Because of the dichotomy of clinical outcomes observed for SHH MB, we first investigated whether the expression profiles of CXCL12 and CXCR4 in SHH and non-SHH MB is associated with tumor histology (desmoplastic vs. non-desmoplastic) and clinical outcome. The gene discussed is CXCR4; the disease is neoplasm.